Multiplex Assays with Fluorescent Microbead Readout: A Powerful Tool, For Mutation Detection (Editorials) Multiplex Assays with Fluorescent Microbead Readout: A Powerful Tool, For Mutation Detection (Editorials)

Multiplex Assays with Fluorescent Microbead Readout: A Powerful Tool, For Mutation Detection (Editorials‪)‬

Clinical Chemistry 2004, Nov, 50, 11

    • 2,99 €
    • 2,99 €

Publisher Description

After the completion of the Human Genome Project, the goal for biomedical research is to apply genomic approaches for the improvement of human health (1). The study of human DNA variation promises to have a great impact on understanding how genetic factors contribute to human disease, conferring susceptibility or resistance; it is also expected to help uncover the reasons that individuals respond differentially to therapeutics. Technologies for mutation detection can be classified into methods for the detection of unknown mutations and methods for the detection of known mutations (2). Methods for the detection of unknown mutations (3-8), also known as screening or scanning methods, are used during the discovery phase. Once a new mutation associated with a genetic disease has been characterized and validated, it is usually detected over and over in many DNA samples by specific, cost-efficient, and easy-to-use methods (9-13), also known as "diagnostic methods" (14).

GENRE
Science & Nature
RELEASED
2004
1 November
LANGUAGE
EN
English
LENGTH
12
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
182.5
KB
Molecular Analysis and Genome Discovery Molecular Analysis and Genome Discovery
2011
Gene Discovery for Disease Models Gene Discovery for Disease Models
2011
Methods for Detection of Point Mutations: Performance and Quality Assessment. Methods for Detection of Point Mutations: Performance and Quality Assessment.
1997
Nucleic Acid Detection Technologies--Labels, Strategies, And Formats. Nucleic Acid Detection Technologies--Labels, Strategies, And Formats.
1999
Sequencing with Microarray Technology--a Powerful New Tool for Molecular Diagnostics (Editorial) Sequencing with Microarray Technology--a Powerful New Tool for Molecular Diagnostics (Editorial)
2000
Chemical Diagnostics Chemical Diagnostics
2013
Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers) Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
1998
Distribution of Adiponectin, Leptin, And Metabolic Correlates of Insulin Resistance: A Longitudinal Study in British Children; 1: Prepuberty (Earlybird 15) (Endocrinology and Metabolism) (Clinical Report) Distribution of Adiponectin, Leptin, And Metabolic Correlates of Insulin Resistance: A Longitudinal Study in British Children; 1: Prepuberty (Earlybird 15) (Endocrinology and Metabolism) (Clinical Report)
2008
The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Peptidome. The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Peptidome.
2006
Interlaboratory Comparison of Fetal Male DNA Detection from Common Maternal Plasma Samples by Real-Time Pcr (Molecular Diagnostics and Genetics) Interlaboratory Comparison of Fetal Male DNA Detection from Common Maternal Plasma Samples by Real-Time Pcr (Molecular Diagnostics and Genetics)
2004
Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?(Pediatric Clinical Chemistry) Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?(Pediatric Clinical Chemistry)
2008
Association of Increased Ferritin with Premature Coronary Stenosis in Men (Lipids, Lipoproteins, And Cardiovascular Risk Factors) Association of Increased Ferritin with Premature Coronary Stenosis in Men (Lipids, Lipoproteins, And Cardiovascular Risk Factors)
2001